|
S1039
|
Rapamycin (Sirolimus) |
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM. |
|
|
|
S1120
|
Everolimus (RAD001) |
Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM. |
|
|
|
S1009
|
BEZ235 (NVP-BEZ235) |
BEZ235 (NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively, and also inhibits ATR with IC50 of 21 nM. |
|
|
|
S1555
|
AZD8055 |
AZD8055 is a novel ATP-competitive inhibitor of mTOR with IC50 of 0.8 nM. |
|
|
|
S1038
|
PI-103 |
PI-103 is a potent, ATP-competitive PI3K inhibitor of DNA-PK, p110α, mTORC1, PI3KC2β, p110δ, mTORC2, p110β, and p110γ with IC50 of 2 nM, 8 nM, 20 nM, 26 nM, 48 nM, 83 nM, 88 nM and 150 nM, respectively. |
|
|
|
S8040
|
GDC-0349 |
GDC-0349, is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM. |
|
|
|
S2811
|
INK 128 (MLN0128) |
INK 128 is a potent and selective mTOR inhibitor with IC50 of 1 nM. |
|
|
|
S2218
|
PP242 |
PP242 is a selective mTOR inhibitor with IC50 of 8 nM. |
|
|
|
S2817
|
Torin 2 |
Torin 2 is a highly potent and selective mTOR inhibitor with IC50 of 0.25 nM, and also exhibits potent cellular activity against ATM/ATR/DNA-PK with EC50 of 28 nM, 35 nM and 118 nM, respectively. |
|
|
|
S2783
|
AZD2014 |
AZD2014 is a novel dual mTORC1 and mTORC2 inhibitor with potential antineoplastic activity. |
|
|
|
S2749
|
NVP-BGT226 |
NVP-BGT226 is a novel dual PI3K/mTOR inhibitor with IC50 of 1 nM. |
|
|
|
S2743
|
PF-04691502 |
PF-04691502 is an ATP-competitive, selective inhibitor of PI3K(α/β/δ/γ)/mTOR with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, also inhibits Akt phosphorylation on T308/S473 with IC50 of 7.5 nM/3.8 nM. |
|
|
|
S2699
|
CH5132799 |
CH5132799 exhibits a strong inhibitory activity especially against PI3Kα with IC50 of 14 nM and also inhibits mTOR with IC50 of 1.6 µM. |
|
|
|
S2696
|
GDC-0980 (RG7422) |
GDC-0980 (RG7422) is a potent, selective inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 5 nM, 27 nM, 7 nM, and 14 nM, and also a mTOR inhibitor with Ki of 17 nM. |
|
|
|
S2827
|
Torin 1 |
Torin1 is a potent inhibitor of mTOR with IC50 of 2-10 nM. |
|
|
|
S2689
|
WAY-600 |
WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM. |
|
|
|
S2661
|
WYE-125132 |
WYE-125132 is a highly potent, ATP-competitive and specific mTOR inhibitor with IC50 of 0.19 nM. |
|
|
|
S2668
|
WYE-687 |
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM. |
|
|
|
S2658
|
GSK2126458 |
GSK2126458 is a highly selective and potent inhibitor of p110α, p110β, p110γ, p110δ, mTORC1 and mTORC2 with Ki of 0.019 nM, 0.13 nM, 0.024 nM, 0.06 nM, 0.18 nM and 0.3 nM, respectively. |
|
|
|
S2628
|
PF-05212384 (PKI-587) |
PKI-587 is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM, respectively. |
|
|
|
S2622
|
PP-121 |
PP-121 is a multi-target inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, respectively, and also inhibits DNA-PK with IC50 of 60 nM. |
|
|
|
S2624
|
OSI-027 |
OSI-027 is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, respectively. |
|
|
|
S2238
|
Palomid 529 |
Palomid 529 (P529) is a PI3K/Akt/mTOR inhibitor for VEGF-A and bFGF with IC50 of 10 nM and 30 nM, respectively. |
|
|
|
S1523
|
XL765 (SAR245409) |
XL765 is a dual inhibitor of mTOR/PI3k for mTOR, p110α, p110β, p110γ and p110δ with IC50 of 157 nM, 39 nM, 113 nM, 9 nM and 43 nM, respectively. |
|
|
|
S1360
|
GSK1059615 |
GSK1059615 is a novel and dual inhibitor of PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ and mTOR with IC50 of 0.4 nM, 0.6 nM, 2 nM, 5 nM and 12 nM, respectively. |
|
|
|
S1266
|
WYE-354 |
WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM. |
|
|
|
S1226
|
Ku-0063794 |
KU-0063794 is a potent and highly specific mTOR inhibitor for both mTORC1 and mTORC2 with IC50 ~10 nM. |
|
|
|
S1044
|
Temsirolimus (Torisel) |
Temsirolimus (CCI-779, Torisel) is a specific mTOR inhibitor with IC50 of 1.76 μM. |
|
|
|
S1022
|
Deforolimus (Ridaforolimus) |
Deforolimus (Ridaforolimus, AP23573, MK-8669) is a selective mTOR inhibitor with IC50 of 0.2 nM. |
|
|